Under valued shares from RPG group investment company

The group consists of over fifteen companies managing diverse business interests in the areas of Automotive Tyres, Infrastructure, IT, Pharmaceuticals, Plantations and Power Ancillaries.

Polyethylene terephthalate production is likely to exceed 24 million tons in 2015

The global annual production capacity of Polyethylene terephthalate

(PET) in 2012 stood at over 28 million tons. Asia-Pacific held about half of the overall capacity, with China ranking first both in the region and throughout the globe. Europe and North America followed after, each accounting for around 14% of the installed capacity of PET production worldwide.

During 2004-2011, the world PET production increased from nearly 11.3 million tons to around 18.6 million tons, registering an average annual growth of over 7%. In 2012, it surpassed the 19.8 million tons mark. 

Asia accounted for the largest share of the world’s total PET production volume, harvesting more than 9.5 million tons of the polyester material. China, the US, Mexico, Taiwan and South Korea were the globe’s top five PET manufacturing countries, with a combined share of nearly 55% of the overall production; their production volume was estimated at over 10.7 million tons in 2012.

Indorama Ventures PCL, 

DAK Americas, 

M&G Group, 

Jiangsu Sanfangxiang Group Co, 

China Resources Packaging, 

JBF Industries Ltd, 

SINOPEC, Octal Holding & Co, 

Shahid Tondgooyan Petrochemical Co, 

Lotte Chemical, 

Far Eastern Textile Ltd and 

Nan Ya Plastics Corp 

are amid the dominant companies engaged in the global PET industry.

The world PET consumption was on an upward trend during 2004-2012. In 2012, it stood at over 19.8 million tons. Asia was the leading PET consumer in the world, followed by Europe and North America. The polyester fiber industry is the major end-user sector for PET – over 60% of the annual supply volume was used in this application in 2012. In the same year, Asia-Pacific was the dominant PET exporter in the world, whilst Europe imported the largest volume of PET.

The PET market is poised to experience positive growth in the upcoming years, driven by a combination of factors such as rapidly increasing global population, improving life standards worldwide, the rising demand from end users, and the upcoming launches of a variety of PET projects. In 2015, the global PET production is likely to exceed 24.39 million tons.

Kovai Medical Center and Hospital on valuation explosion and growth tragectory

Extracts from the Annual Report 2013-14 of  Kovai Medical Centre Hospital

Last year, we ended the annual report mentioning our desire to start liver
transplant and a world-class cardiac center. Both the dreams became a
reality. Dr.Prashant Vaijyanath, a cardiac surgeon of international repute,
was recruited as Director, Cardiovascular and Thoracic Surgery. His
capabilities has transformed the face of cardiac surgery in the region. The
joining of Dr. Olith Selvan and Dr.Magnus Jayaraj Mansard on the other
hand enabled us to start liver transplant surgery.

Cardiac transplant
Although cardiac transplant has been around for more than four decades,
hardly two cities viz. New Delhi and Chennai have been able to successfully
carry out this path-breaking surgery in India.
http://www.dmrhs.org/tnos/notifications/list-of-approved-hospitals-for-heart-transplantation
Kovai Medical Center and Hospital created history by performing the first cardiac transplant
successfully in Coimbatore for an extremely sick patient. The team headed
by Dr.Prashant Vaijyanath was able to transfer the heart from a 45 years old
brain dead man to a 24 years old young man in a record time of 45 minutes.

https://www.apollohospitals.com/centre-of-excellence-heart-institute.php


The team is confident of starting lung transplant in the near future.


The Members of the Company on 23 August 2011 had approved the borrowings by the Company for an
amount not exceeding 750 Crore (Rupees Seven hundred and fifty crore only) and creation of charge to
secure the borrowings vide Ordinary Resolution(s) under Section 293(1) (d) and 293(1)(a) of Companies
Act, 1956 which is valid for a period of one year from the date of notification of Section 180 of the
Companies Act, 2013.

Your Hospital continues to show robust performance year-on-year and it has to keep investing substantial
amount to increase the bed capacity in existing centers and have to invest continuously in new
technologies, modernization of facilities and expansion of services.
We believe that these investments will help us to attract and retain Doctors and make our Hospitals a preferred destination for patients.
Moreover as part of our ambitious growth plans, we are also contemplating to take up new projects at
different locations other than Coimbatore.

Therefore, it is considered desirable to enhance the borrowing limits to 1000 crore (Rupees One
thousand crore only) apart from temporary loans obtained / to be obtained by the company from its
Bankers in the ordinary course of business.


The Hospital in order to enhance the patient satisfaction has decided to add 150 beds to its existing
capacity - 75 beds for Emergency & Intensive Care and 75 beds for patient rooms at Main Center. In
addition, it has also undertaken modernization / renovation work at Erode Center as well as at City Center.
The capital expenditure for the above plans outlined will be approximately 80 crore.

As a part of our ambitious growth plans, we plan to set up a new Hospital in Chennai in order to reach out to
wider population. It is envisaged to have a 300 bed Hospital at an estimated cost of 300 crore.
The above projects will be funded by existing funds, internal accruals, incremental debt and equity. It is
always our endeavor to provide improved outcomes to patients and in this regard we have added one
more speciality i.e. liver transplant.

Health care Industry in India
At the turn of this century, health outcomes in India and the quality of the underlying health system
significantly lagged those of peer nations. From such weak beginning Indian health care industry, has
made steady progress, but remain inadequate on most parameters.

In India, health care sector suffers from underfunding and bad governance. India has made huge
improvements since independence, but majority (70 percent) of the effort has been private sector led.

Still India accounts for 21 percent of the world's burden of disease – Courtesy Wikipedia.
Though the Government spending on health care is inadequate, it plans to increase it further by 2.5
percent of the GDP in the 12 five year plan. The amount of public fund that India invests in health care is
very small compared to other emerging economies.

With 6 percent of GDP expenditure on health care, India ranks among the bottom five countries with the lowest public health spending globally.

As per the study by CRISIL Research, the health care delivery industry is expected to grow at 12 percent
CAGR to reach 3,500 billion by 2014-15. According to CRISIL, owing to the shortages in public health
care delivery in India, private expenditure on health care accounts for nearly 75 percent of overall health
care expenditure in the country and is the highest in the world.

Health care in India today provides existing and new players with a unique opportunity to achieve
innovation, differentiation and profits. In the next decade, increasing consumer awareness and demand
for better facilities will redefine the country's second largest service sector employer.
India's primary competitive advantage over its peers lies in its large pool of well-trained medical
professionals. Also, India's cost advantage compared to peers in Asia and Western countries is
significant. Cost of surgery in India is one-tenth of that in theUSor Western Europe.

To improve the India's health care access, paradigm shift is required from `infrastructure focus' to
`productivity focus'. This can only be achieved if larger fund allocation for health care is accompanied by
effective and innovative interventions to improve the existing health care ecosystem.

The Indian healthcare industry in India is rapidly growing and is being fueled by large investments from
existing corporate hospital chains as well as new entrants backed by private equity investors. This is a
clear indication that health care is going to be a major sector that stimulates the economic growth. The
healthcare industry forms the backbone of any nation's well being and can be broadly divided into five
segments namely hospitals, pharmaceuticals, diagnostics, medical equipment & supplies and medical
insurance.

Road Ahead
OPPORTUNITIES
Drivers of growth
Increasing Health awareness
Rising income levels
Telemedicine is a fast emerging sector in India, In 2012, the telemedicine market in India was valued at
US$ 7.5 million and is expected to grow at aCAGRof 20 percent to US$ 18.7 million by 2017.
India's competitive advantage also lies in the increased success rate of Indian companies in getting
Abbreviated New Drug Application (ANDA) approvals. India also offers vast opportunities in R&D as well
as medical tourism.
The Indian medical tourism industry is pegged at US$ 1 billion per annum, growing at around 18 percent
and is expected to touch US$ 2 billion by 2015.
There is a significant scope for enhancing healthcare services considering that healthcare spending as a
percentage of GDP is rising. Rural India, which accounts for over 70 percent of the population, is set to
emerge as a potential demand source. Only 3 percent of the specialist physicians cater to rural demand.
There are vast opportunities for investment in healthcare infrastructure in both urban and rural India.
About 1.8 million beds are required by the end of 2025. Additionally, 1.54 million doctors and 2.4 million
nurses are required to meet the growing demand.
Source: India Brand Equity Foundation (IBEF)
India's population is expected to grow from around 1.1 billion in 2009-10 to over 1.4 billion by 2026. The
number of treatments required is therefore expected to increase in tandem. As current health care
delivery system remains woefully inadequate, there is tremendous opportunity for growth.
With the rise in literacy levels across the country, greater percentage of population understands the need
for preventive and corrective health care facility. It is likely to increase the demand for health care delivery
services.
Steady increase of disposable income is expected to create higher demand for quality health care though
health care is largely considered a non-discretional expense.


Change in disease profile
Health Insurance coverage
Medical Tourism
High capital investment
Obsolescence of medical equipments
Increasing inflation
Factors like changing demographics, rising disposable income and change in dietary patterns lead to
increased incidence of life style related diseases. All these will result in increased demand for quality
health care services.
Presently 95 percent of India's private health care expenditure is in the form of out-of-pocket expenditure
as health insurance coverage is under 5 percent. This gives opportunity for cheaper penetration of health
insurance which is likely to become more affordable for a larger percentage of the population.
Medical tourism has gained momentum over the years and India is fast emerging as a major medical
tourist destination. As governments across the globe and patients worldwide struggle with soaring health
care costs, the relatively low cost of surgery and critical care in India is drawing the attention of global
healthcare providers.
The performance of health care industry has been very encouraging and as a result of the significant
growth and opportunities in the industry, many new players are entering into hospital sector. This is
causing increased competition for business, man power, market share etc.
The health care industry is capital intensive and substantial capital amounts are required for establishing
and modernising hospitals.
Rapid technological change in the medical equipments is a common factor in health care industry. The
product innovation and evolving technologies push the health care industry to frequently upgrade its
equipments.
The inflation in India is continuously on the increase. This could cause spurt in the cost of transportation,
wages, raw materials and equipments.


Shortage of skilled manpower
EXPANSIONPLAN

Increasing health awareness, rising income levels, emergence of various domestic hospital chains have
increased the demand for medical professionals, para-medical staff, nurses, technicians etc. putting
pressure on the available resources.

SRS Ltd will it shine

The SRS 'Sab Rahen Saath' Group is a dynamic and diversified business house, Headquartered at Faridabad, New Delhi NCR, it is driven by a vision to grow by offering innovative and superior products & services, while enriching the society as a whole.

SRS Limited is a part of the larger SRS Group, which has a turnover of Rs.5000 crores and additional interests in real estate, financial services and healthcare sectors. SRS group was ranked at the 2nd position By Business World in May 2013 in the middleweight organisations category. Further, SRS Limited was ranked as the 48th fastest growing company in 2013-14 by Business World in its July 2014 issue.

The SRS Group believes that sustainable success comes through staying together as a team and realizing extraordinary victories. This understanding translates into the Group's commitment to keep all the members of the extended corporate family together - small wonder then that its name simply expands into .with a strong presence

SRS Ltd has presence across multiple sectors that include

Gold & Jewellery http://srsjewells.com/

SRS Ltd is into wholesaling and retailing of jewellery. It sells a wide range of gold and diamond jewellery under the brand name of SRS Jewells. The product portfolio includes gold coins,  necklaces, rings, pendants, bracelets, earrings, bangles etc. Skilled craftsmen are employed  by the Company for manufacturing of jewellery pieces based on international and trendy designs. The jewellery is procured from the group's domestic manufacturing facility at Patparganj, New  Delhi and through third parties. The Company at present has 8 retail showrooms at Delhi,  Faridabad, Noida, Ghaziabad and Palwal and 4 wholesale outlets at Delhi, Mumbai and  Ahmedabad. The export operations are carried out through its 100% EOU at Noida SEZ. Dubai, Doha, US, UK, Hongkong, Singapore etc are the target markets for jewellery exports.

NEW DELHI :

F-140, MAIN MARKET, RAJOURI GARDEN, NEW DELHI-110027

KAROL BAGH :

OPP. POST OFFICE, GURDWARA ROAD, KAROL BAGH, NEW DELHI-110005.

NOIDA:

G-64, MAIN MARKET, SECTOR-18, NOIDA-201301

GHAZIABAD :

PLOT NO.57, MAIN MARKET, AMBEDKAR ROAD, GHAZIABAD-201001

FARIDABAD :

NIT, FARIDABAD :SCF PLOT NO. 6-A, NEHRU GROUND, NIT, FARIDABAD-121006 

SEC-12, FARIDABAD :SRS MALL, SEC-12, FARIDABAD-121007 

PALWAL:

COMMITTEE CHOWK, PALWALNEAR DEVI MANDIR, COMMITTEE CHOWK, PALWAL – 121102

NH-2, PALWAL NEAR SRS VALUE BAZAAR, AGRA CHOWK, NH-2, PALWAL 

MUMBAI:

SHOP NO. 201, 2ND FLOOR, JEWEL WORLD, COTTON EXCHANGE
BUILDING,175,KALBA DEVI ROAD, ZAVERI BAZAAR, MUMBAI-400002.

DELHI:

1165, 2ND FLOOR, KUCHA MAHAJANI, CHANDNI CHOWK, DELHI. 

S-4, IIND FLOOR, BUILDING NO. 2609, CORNER BUILDING,BANK STREET, KAROL BAGH, NEW DELHI 

AHMEDABAD:

SHOP NO.GF-10, SUPPER MALL, NEAR LAL BUNGALOW, CG ROAD,NAVRANGPURA.AHMEDABAD

Cinemas, http://srsparivar.com/cinemas/index.php

SRS Cinemas is the film exhibition brand under which the Company operates a chain of multiplexes spread across 11 cities. This includes 16 properties at strategic locations with a combined strength of 45 screens and 11453 seats. It is a brand that is fast spreading its footprint across the major cities of North India

Retail, http://srsparivar.com/value-bazaar/index.php
The SRS Group operates a chain of retail stores under the brand name of SRS Value Bazaar that offer FMCG products including food and groceries, apparels, cosmetics / home care / personal care products, crockery, appliances, accessories, etc. SRS Fashion Wear is the other brand which retails multi-brand apparels. The Company has 22 retail stores in North India with a total floor space of more that 165000. sq. ft. 

Hotel, http://www.srshotels.net/ 
Hotel at  Haridwar is  amongst the most beautifully designed and luxurious hotels in Uttarakhand that offers real value for money, SRS Lakshya hotel happens to be the first in Haridwar having its own central air conditioning plant and an in-house express laundry and dry cleaning service for its guests. It features 78 rooms including 3 Presidential Suites, 4 Deluxe Suites and 71 Deluxe Rooms. True to its style, SRS Limited is bringing in a fresh wave of marketing and operational power to make SRS Lakshya the choice of domestic and international travellers alike, by delivering one of the finest hospitality experience

Food & Beverages http://srsparivar.com/7dayz/index.php

The food & beverages segment of the Company operates a chain of food courts, fine dining restaurants and banquets across several cities. The food courts are run under the SRS 7dayz brand and currently, the Company operates 8 food courts across North and Central India. The fine dining restaurants are operated under the brand Punjabi Haandi and currently, the Company operates 3 Fine Dining Restaurants that are located at Faridabad, Gorakhpur and Ludhiana. In addition to this, Flamez is another trendy restrobar that offers a premium fine-dining experience. Located at the SRS Mall, Fairdabad, it thrills people with its dance floor as well, and is one of the hottest spots in the area. All these outlets are strategically located at high footfalls areas such as malls and high street markets to ensure higher visibility and walk-ins. Apart from this, the Company offers indoor and outdoor catering services through its brand SRS Banquets, which is located at Faridabad. The SRS 7dayz brand also sells packaged snack food by way of a wide range of namkeens, that are sold through the group’s own retail stores as well as through other retailers

Financing Services,
Real Estate and Health Care.

10 Stock to own and 10 stock to shun

10 Stock to own based on performance in FY2015 Q1

Company name	Sales (Rs crore)		Net Profit (Rs crore)
	Jun-14	Jun-13	%Chg	Jun-14	Jun-13	%Chg
TCS	17,438	13,944	25	5,097	3,298	55
HDFC Bank	11,220	9,663	16	2,233	1,844	21
Wipro	9,963	8,732	14	2,067	1,306	58
Bharti Infratel	1,323	1,193	11	1,207	441	174
Idea Cellular	7,483	6,470	16	643	404	59
IndusInd Bank	2,297	1,912	20	421	335	26
Indiabulls Hsg	1,270	1,164	9	412	327	26
Ambuja Cements	2,706	2,346	15	409	324	26
JSW Energy	1,691	1,465	15	239	167	43
Federal Bank	1,772	1,653	7	220	106	108

10 Stock to shun based on performance in FY2015 Q1

Company name	Sales (Rs crore)		Net Profit (Rs crore)
	Jun-14	Jun-13	%Chg	Jun-14	Jun-13	%Chg
Cairn India	2375	2133	11	644	1989	-68
Reliance Infra	2524	3265	-23	321	374	-14
Shriram Trans	2016	1864	8	306	341	-10
Zee Entertain	789	708	12	210	250	-16
Indian Bank	3929	3666	7	207	317	-35
M&M Financial	1275	1092	17	155	191	-19
ING Vysya Bank	1400	1309	7	143	175	-18
Colgate	951	845	13	135	185	-27
Allahabad Bank	5049	4564	11	113	413	-73
Glenmark	593	508	17	104	118	-12

Piramal Enterprises DY 7.5% Ex-Div 15Jul2014

What will happen to price Piramal Enterprises shares
post Ex Dividend dates 15 Jul 2014 from CMP of Rs.698

Piramel Enterprises shares now quoting at Rs 698 gives a dividend yield of 7.52%
BSE: 500302 NSE: PEL ISIN: INE140A01024
A) it will fall by 7.5% to compensate to dividend of Rs 52.5 in which case all who bought shares at 698 will be in no profit / no loss zone
B) it will remain at around 698 in which case all those who bought shares even at 698 will be at marginal profits of 7.5^%
C) it will fall drastically to Rs 560 level being the lower circuit limit for the daywherein all those who bought shares post May 2014 will be at loss
D) it will move up considering Rs 189 per share net accrection in value as detailed below
 i) the profit of Rs 2400 crore net of tax in Vodaphone share sale (EPS 139.20) in Apr -June quarter
ii) the accretion in price of Piramel's investment in Shriram City Union Finance by Rs 29 8 crore (EPS17.25) in Apr June quarter
iii) the accretion in price of Piramel's investment in Shriram Transport Finance by Rs 442 crore (EPS 30.98) in Apr June quarter -
My target for Piramal Enterprises is Rs 840 for the six months with a stop loss of Rs. 640

http://www.nseindia.com/live_market/dynaContent/live_watch/get_quote/GetQuote.jsp?symbol=PELhttp://www.bseindia.com/stock-share-price/piramal-enterprises-ltd/piramal-ent/500302/http://www.moneycontrol.com/india/stockpricequote/pharmaceuticals/piramalenterprises/PH05http://profit.ndtv.com/stock/piramal-enterprises-ltd_pel/http://www.indiainfoline.com/Markets/Company/Piramal-Enterprises-Ltd/500302

And the answer was that stock piramal entreprises
on 15.07.2014 was quoting at Rs. 632.35 on NSE down 9.4% or Rs. 65.65
on 16.07.2014 was quoting at Rs 647.15 on NSE recovering 2.34% or Rs 14.80

NSE Down Price band of 3 securities wef July 07, 2014

NSE in pursuance of Capital Market Segment Regulation Part- A, 2.5, the price bands for list of 3 numbers of securities in whose price band has been revised down to 10 /5  from 20 to 20%  with effect from July 07, 2014 shall be as follows

Symbol	Series	Security Name	From	To	ISIN
PUNJABCHEM	EQ	Punjab Chemicals & Crop Protection Limited	10	5	INE277B01014
EXCELCROP	EQ	Excel Crop Care Limited	20	10	INE223G01017
GUFICBIO	EQ	Gufic Biosciences Limited	20	10	INE742B01025

Source : http://www.nseindia.com/content/circulars/SURV27087.zip

NSE UP's Price band of 85 securities from 10 to 20% wef July 07, 2014

NSE in pursuance of Capital Market Segment Regulation Part- A, 2.5, the price bands for list of 85 numbers of securities in whose price band has been revised up from 10 to 20%  with effect from July 07, 2014 shall be as follows
Source : http://www.nseindia.com/content/circulars/SURV27087.zip

Symbol	Series	Security Name	From	To	ISIN
AARTIDRUGS	EQ	Aarti Drugs Limited	10	20	INE767A01016
ALEMBICLTD	EQ	Alembic Limited	10	20	INE426A01027
ALOKTEXT	EQ	Alok Industries Limited	10	20	INE270A01011
ANSALHSG	EQ	Ansal Housing and Construction Limited	10	20	INE880B01015
APARINDS	EQ	Apar Industries Limited	10	20	INE372A01015
ARCOTECH	EQ	Arcotech Limited	10	20	INE574I01027
ATUL	EQ	Atul Limited	10	20	INE100A01010
AURIONPRO	EQ	Aurionpro Solutions Limited	10	20	INE132H01018
AXIS-IT&T	EQ	Axis-IT&T Limited	10	20	INE555B01013
BAJAJHIND	EQ	Bajaj Hindusthan Limited	10	20	INE306A01021
BGRENERGY	EQ	BGR Energy Systems Limited	10	20	INE661I01014
BSLIMITED	EQ	BS LIMITED	10	20	INE043K01029
CANFINHOME	EQ	Can Fin Homes Limited	10	20	INE477A01012
CENTURYPLY	EQ	Century Plyboards (India) Limited	10	20	INE348B01021
CERA	EQ	Cera Sanitaryware Limited	10	20	INE739E01017
DEEPIND	EQ	Deep Industries Limited	10	20	INE677H01012
DHUNINV	EQ	Dhunseri Investments Limited	10	20	INE320L01011
DREDGECORP	EQ	Dredging Corporation of India Limited	10	20	INE506A01018
ELECON	EQ	Elecon Engineering Company Limited	10	20	INE205B01023
FACT	EQ	Fertilizers and Chemicals Travancore Limited	10	20	INE188A01015
FCEL	EQ	Future Consumer Enterprise Limited	10	20	INE220J01025
FEDDERLOYD	EQ	Fedders Lloyd Corporation Limited	10	20	INE249C01011
GANESHHOUC	EQ	Ganesh Housing Corporation Limited	10	20	INE460C01014
GINNIFILA	EQ	Ginni Filaments Limited	10	20	INE424C01010
GITANJALI	EQ	Gitanjali Gems Limited	10	20	INE346H01014
GOKEX	EQ	Gokaldas Exports Limited	10	20	INE887G01027
GOLDINFRA	EQ	Goldstone Infratech Limited	10	20	INE260D01016
HARRMALAYA	EQ	Harrisons Malayalam Limited	10	20	INE544A01019
HBSTOCK	EQ	HB Stockholdings Limited	10	20	INE550B01014
HCL-INSYS	EQ	HCL Infosystems Limited	10	20	INE236A01020
HITECHGEAR	EQ	Hi-Tech Gears Limited	10	20	INE127B01011
HMT	EQ	HMT Limited	10	20	INE262A01018
IL&FSTRANS	EQ	IL&FS Transportation Networks Limited	10	20	INE975G01012
IMFA	EQ	Indian Metals & Ferro Alloys Limited	10	20	INE919H01018
ITI	EQ	ITI Limited	10	20	INE248A01017
IVP	EQ	IVP Limited	10	20	INE043C01018
JENSONICOL	EQ	Jenson & Nicholson (India) Limited	10	20	INE819B01021
JINDALPOLY	EQ	Jindal Poly Films Limited	10	20	INE197D01010
JINDALSAW	EQ	Jindal Saw Limited	10	20	INE324A01024
JINDRILL	EQ	Jindal Drilling And Industries Limited	10	20	INE742C01031
JKLAKSHMI	EQ	JK Lakshmi Cement Limited	10	20	INE786A01032
JYOTISTRUC	EQ	Jyoti Structures Limited	10	20	INE197A01024
KABRAEXTRU	EQ	Kabra Extrusion Technik Limited	10	20	INE900B01029
KCP	EQ	KCP Limited	10	20	INE805C01028
KEI	EQ	KEI Industries Limited	10	20	INE878B01027
KHANDSE	EQ	Khandwala Securities Limited	10	20	INE060B01014
KITEX	EQ	Kitex Garments Limited	10	20	INE602G01020
KOLTEPATIL	EQ	Kolte - Patil Developers Limited	10	20	INE094I01018
MAANALU	EQ	Maan Aluminium Limited	10	20	INE215I01019
MAXWELL	EQ	Maxwell Industries Limited	10	20	INE450G01024
MMTC	EQ	MMTC Limited	10	20	INE123F01029
MOHITIND	EQ	Mohit Industries Limited	10	20	INE954E01012
MONNETISPA	EQ	Monnet Ispat and Energy Limited	10	20	INE743C01013
MORARJEE	EQ	Morarjee Textiles Limited	10	20	INE161G01027
NAGREEKEXP	EQ	Nagreeka Exports Limited	10	20	INE123B01028
NBCC	EQ	National Buildings Construction Corporation Limited	10	20	INE095N01015
NBVENTURES	EQ	Nava Bharat Ventures Limited	10	20	INE725A01022
NFL	EQ	National Fertilizers Limited	10	20	INE870D01012
NGCT	EQ	Northgate Com Tech Limited	10	20	INE970N01019
PATINTLOG	EQ	Patel Integrated Logistics Limited	10	20	INE529D01014
PDPL	EQ	Parenteral Drugs (India) Limited	10	20	INE904D01019
PFRL	EQ	Pantaloons Fashion & Retail Limited	10	20	INE647O01011
PPAP	EQ	Precision Pipes And Profiles Company Limited	10	20	INE095I01015
PRAKASH	EQ	Prakash Industries Limited	10	20	INE603A01013
PRESSMN	EQ	Pressman Advertising Limited	10	20	INE980A01023
PSB	EQ	Punjab & Sind Bank	10	20	INE608A01012
RAIN	EQ	Rain Industries Limited	10	20	INE855B01025
RUBYMILLS	EQ	The Ruby Mills Limited	10	20	INE301D01026
SAMBANDAM	EQ	Sambandam Spinning Mills Limited	10	20	INE304D01012
SANWARIA	EQ	Sanwaria Agro Oils Limited	10	20	INE890C01046
SBT	EQ	State Bank of Travancore	10	20	INE654A01024
SESHAPAPER	EQ	Seshasayee Paper and Boards Limited	10	20	INE630A01016
SINTEX	EQ	Sintex Industries Limited	10	20	INE429C01035
SKMEGGPROD	EQ	SKM Egg Products Export (India) Limited	10	20	INE411D01015
SMSPHARMA	EQ	SMS Pharmaceuticals Limited	10	20	INE812G01017
STERTOOLS	EQ	Sterling Tools Limited	10	20	INE334A01015
TEXRAIL	EQ	Texmaco Rail & Engineering Limited	10	20	INE621L01012
THINKSOFT	EQ	Thinksoft Global Services Limited	10	20	INE201K01015
TRIDENT	EQ	Trident Limited	10	20	INE064C01014
TTML	EQ	Tata Teleservices (Maharashtra) Limited	10	20	INE517B01013
UTTAMVALUE	EQ	Uttam Value Steels Limited	10	20	INE292A01015
VHL	EQ	Vardhman Holdings Limited	10	20	INE701A01023
ZANDUREALT	EQ	Zandu Realty Limited	10	20	INE719A01017
ZEEMEDIA	EQ	Zee Media Corporation Limited	10	20	INE966H01019
ZODIACLOTH	EQ	Zodiac Clothing Company Limited	10	20	INE206B01013